- Home
- HYI vs RXST Comparison
HYI vs RXST Comparison
Compare HYI & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYI
- RXST
- Stock Information
- Founded
- HYI 2010
- RXST 1997
- Country
- HYI United States
- RXST United States
- Employees
- HYI N/A
- RXST N/A
- Industry
- HYI Investment Managers
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- HYI Finance
- RXST Health Care
- Exchange
- HYI Nasdaq
- RXST Nasdaq
- Market Cap
- HYI 272.7M
- RXST 307.3M
- IPO Year
- HYI N/A
- RXST 2021
- Fundamental
- Price
- HYI $11.47
- RXST $8.74
- Analyst Decision
- HYI
- RXST Hold
- Analyst Count
- HYI 0
- RXST 11
- Target Price
- HYI N/A
- RXST $11.80
- AVG Volume (30 Days)
- HYI 50.6K
- RXST 717.0K
- Earning Date
- HYI 01-01-0001
- RXST 11-06-2025
- Dividend Yield
- HYI 9.59%
- RXST N/A
- EPS Growth
- HYI N/A
- RXST N/A
- EPS
- HYI N/A
- RXST N/A
- Revenue
- HYI N/A
- RXST $147,059,000.00
- Revenue This Year
- HYI N/A
- RXST N/A
- Revenue Next Year
- HYI N/A
- RXST $6.71
- P/E Ratio
- HYI N/A
- RXST N/A
- Revenue Growth
- HYI N/A
- RXST 27.68
- 52 Week Low
- HYI $10.99
- RXST $6.32
- 52 Week High
- HYI $12.24
- RXST $55.57
- Technical
- Relative Strength Index (RSI)
- HYI 36.61
- RXST 52.86
- Support Level
- HYI $11.33
- RXST $7.40
- Resistance Level
- HYI $11.55
- RXST $8.79
- Average True Range (ATR)
- HYI 0.10
- RXST 0.41
- MACD
- HYI -0.01
- RXST 0.05
- Stochastic Oscillator
- HYI 34.67
- RXST 78.99
About HYI Western Asset High Yield Defined Opportunity Fund Inc.
Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. The fund invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.